These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 2851670

  • 1. [Technetium-99m-pyrophosphate single photon emission computed tomography of the heart in familial amyloid polyneuropathy: comparison with thallium-201 myocardial scintigraphy--a case report].
    Imamoto T, Morita K, Onodera S, Tanazawa S, Amoh K, Ishikawa Y, Murakami N, Kawachi H.
    Kaku Igaku; 1988 Oct; 25(10):1117-23. PubMed ID: 2851670
    [No Abstract] [Full Text] [Related]

  • 2. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
    Takezaki M, Ishida Y, Morozumi T, Tani A, Sato H, Hori M, Kitabatake A, Kamada T, Kimura K, Kozuka T.
    Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
    [Abstract] [Full Text] [Related]

  • 3. Technetium-99m pyrophosphate single-photon emission computed tomography of the heart in familial amyloid polyneuropathy.
    Karp K, Näslund U, Backman C, Eriksson P.
    Int J Cardiol; 1987 Mar; 14(3):365-9. PubMed ID: 3030945
    [Abstract] [Full Text] [Related]

  • 4. [Diagnostic significance of technetium-99m-pyrophosphate, technetium-99m-methylene diphosphonate and gallium-67-citrate scintigraphy in amyloid heart disease--a study with AL amyloidosis and familial amyloid polyneuropathy].
    Hongo M, Misawa T, Yamada H, Hirayama J, Okubo S, Fujii T, Kusama S, Ikeda S.
    Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):1-8. PubMed ID: 3009667
    [No Abstract] [Full Text] [Related]

  • 5. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S, Ikeda S.
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [Abstract] [Full Text] [Related]

  • 6. Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy.
    Hongo M, Hirayama J, Fujii T, Yamada H, Okubo S, Kusama S, Ikeda S.
    Am Heart J; 1987 Mar; 113(3):654-62. PubMed ID: 3030086
    [Abstract] [Full Text] [Related]

  • 7. Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.
    Eriksson P, Backman C, Bjerle P, Eriksson A, Holm S, Olofsson BO.
    Br Heart J; 1984 Sep; 52(3):321-6. PubMed ID: 6087862
    [Abstract] [Full Text] [Related]

  • 8. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
    Falk RH, Lee VW, Rubinow A, Hood WB, Cohen AS.
    Am J Cardiol; 1983 Mar 01; 51(5):826-30. PubMed ID: 6299087
    [Abstract] [Full Text] [Related]

  • 9. [A case of familial amyloid polyneuropathy demonstrating marked myocardial uptake of technetium-99m-pyrophosphate].
    Kawashima A, Hongo M, Matsuoka K, Soga N, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S.
    Nihon Naika Gakkai Zasshi; 1985 Jun 01; 74(6):774-9. PubMed ID: 2995520
    [No Abstract] [Full Text] [Related]

  • 10. [New application of myocardial infarct map using a dual isotope single photon emission computed tomography (SPECT) of [99mTc]pyrophosphate and [201Tl]chloride in patients with acute myocardial infarction].
    Hiroe M, Muramatsu Y, Sugimoto K, Tsujino M, Maejima M, Miyahara Y, Taniguchi K, Matsui S, Mizukawa K.
    Kaku Igaku; 1988 Oct 01; 25(10):1125-9. PubMed ID: 2851671
    [No Abstract] [Full Text] [Related]

  • 11. Usefulness of technetium pyrophosphate scintigraphy in demonstrating cardiac amyloidosis in persons aged 85 years and older.
    Goldstein SA, Lindsay J, Chandeysson PL, Nolan NG.
    Am J Cardiol; 1989 Mar 15; 63(11):752-3. PubMed ID: 2538049
    [No Abstract] [Full Text] [Related]

  • 12. Technetium 99m-pyrophosphate scintigraphy in amyloid cardiomyopathy.
    Ptacin MJ, Bamrah V, Duthie E.
    Wis Med J; 1985 Mar 15; 84(3):25-7. PubMed ID: 2986368
    [No Abstract] [Full Text] [Related]

  • 13. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis].
    Volpi A, Cavalli A, Maggioni AP, Inglese E, Rovelli GE, Neri R, Salvi A.
    G Ital Cardiol; 1985 Sep 15; 15(9):925-9. PubMed ID: 3002892
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of technetium-99m pyrophosphate myocardial scintigraphy in amyloid polyneuropathy and correlation with echocardiography.
    Fournier C, Grimon G, Rinaldi JP, Terral A, Boujon B, Adams D, Desgrez A, Blondeau M.
    Am J Cardiol; 1993 Oct 01; 72(11):854-7. PubMed ID: 8213531
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.
    Gertz MA, Brown ML, Hauser MF, Kyle RA.
    Arch Intern Med; 1987 Jun 01; 147(6):1039-44. PubMed ID: 3036031
    [Abstract] [Full Text] [Related]

  • 17. Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis.
    Falk RH, Lee VW, Rubinow A, Skinner M, Cohen AS.
    Am J Cardiol; 1984 Nov 01; 54(8):1150-1. PubMed ID: 6093493
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.